Market Closed -
OTC Markets
03:48:02 2024-04-26 pm EDT
|
5-day change
|
1st Jan Change
|
0.18
USD
|
-1.10%
|
|
-11.07%
|
-18.18%
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
107.5
|
219.4
|
227.1
|
134.9
|
65.8
|
53.85
|
Enterprise Value (EV)
1 |
107.5
|
219.7
|
227.6
|
135.1
|
66.47
|
54.54
|
P/E ratio
|
-17.8
x
|
-32.6
x
|
-14
x
|
-4.36
x
|
-38.8
x
|
-20.1
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
2,345
x
|
44,526
x
|
353,169
x
|
2,286,322
x
|
1,755
x
|
-
|
EV / Revenue
|
2,344
x
|
44,597
x
|
353,968
x
|
2,289,665
x
|
1,773
x
|
-
|
EV / EBITDA
|
-
|
-
|
-
|
-
|
-23,757,245
x
|
-22,514,742
x
|
EV / FCF
|
-247
x
|
310
x
|
64.6
x
|
14.7
x
|
-109
x
|
-34.1
x
|
FCF Yield
|
-0.41%
|
0.32%
|
1.55%
|
6.79%
|
-0.92%
|
-2.94%
|
Price to Book
|
-307
x
|
-242
x
|
-238
x
|
-118
x
|
-31.9
x
|
-31.4
x
|
Nbr of stocks (in thousands)
|
170,673
|
179,085
|
189,240
|
228,632
|
230,871
|
244,783
|
Reference price
2 |
0.6300
|
1.225
|
1.200
|
0.5900
|
0.2850
|
0.2200
|
Announcement Date
|
4/1/19
|
7/9/20
|
3/30/21
|
4/1/22
|
3/28/23
|
4/1/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
0.0459
|
0.004927
|
0.000643
|
0.000059
|
0.0375
|
-
|
EBITDA
|
-
|
-
|
-
|
-
|
-2.798
|
-2.422
|
EBIT
1 |
-2.378
|
-6.094
|
-14.85
|
-29.8
|
-2.802
|
-2.427
|
Operating Margin
|
-5,184.18%
|
-123,688.09%
|
-2,309,276.98%
|
-50,509,550.85%
|
-7,472.1%
|
-
|
Earnings before Tax (EBT)
1 |
-6.006
|
-6.602
|
-15.71
|
-30.55
|
-1.688
|
-2.623
|
Net income
1 |
-6.006
|
-6.602
|
-15.71
|
-30.55
|
-1.688
|
-2.623
|
Net margin
|
-13,096.1%
|
-134,002.33%
|
-2,443,452.57%
|
-51,778,276.27%
|
-4,500%
|
-
|
EPS
2 |
-0.0353
|
-0.0375
|
-0.0855
|
-0.1353
|
-0.007345
|
-0.0110
|
Free Cash Flow
1 |
-0.436
|
0.7091
|
3.522
|
9.174
|
-0.6116
|
-1.601
|
FCF margin
|
-950.7%
|
14,392.06%
|
547,669.36%
|
15,549,084.75%
|
-1,630.84%
|
-
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
4/1/19
|
7/9/20
|
3/30/21
|
4/1/22
|
3/28/23
|
4/1/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
-
|
0.35
|
0.51
|
0.2
|
0.67
|
0.69
|
Net Cash position
1 |
0.02
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-0.241
x
|
-0.2846
x
|
Free Cash Flow
1 |
-0.44
|
0.71
|
3.52
|
9.17
|
-0.61
|
-1.6
|
ROE (net income / shareholders' equity)
|
1,957%
|
1,252%
|
1,692%
|
2,916%
|
105%
|
139%
|
ROA (Net income/ Total Assets)
|
-316%
|
-3,685%
|
-5,976%
|
-15,273%
|
-928%
|
-478%
|
Assets
1 |
1.899
|
0.1792
|
0.2629
|
0.2
|
0.1818
|
0.5493
|
Book Value Per Share
2 |
-0
|
-0.0100
|
-0.0100
|
-0
|
-0.0100
|
-0.0100
|
Cash Flow per Share
2 |
0
|
0
|
0
|
0
|
0
|
0
|
Capex
|
-
|
-
|
0.1
|
-
|
-
|
-
|
Capex / Sales
|
-
|
-
|
15,762.05%
|
-
|
-
|
-
|
Announcement Date
|
4/1/19
|
7/9/20
|
3/30/21
|
4/1/22
|
3/28/23
|
4/1/24
|
|
1st Jan change
|
Capi.
|
---|
| -18.18% | 44.57M | | +73.17% | 12.38B | | -18.74% | 7.92B | | +16.15% | 7.2B | | +4.81% | 5.84B | | +5.99% | 5.01B | | +27.07% | 4.53B | | -21.67% | 3.88B | | -40.82% | 2.23B | | +1.49% | 2.02B |
Medical Equipment
|